ID
41157
Beskrivning
Study ID: 103471 Clinical Study ID: 103471 Study Title: A randomised, double blind, placebo-controlled, double dummy, five-way cross over dose-escalation study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single inhaled doses of GSK233705 (20-500µg via DPI), and, tiotropium bromide (18µg via DPI) in healthy male subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Darotropium Bromide Trade Name: Darotropium Bromide Study Indication: Chronic Obstructive Pulmonary Disease (COPD)
Nyckelord
Versioner (1)
- 2020-07-02 2020-07-02 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
2 juli 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Safety, tolerability, pharmacokinetics and pharmacodynamics of GSK233705 and tiotropium bromide (103471)
Physical Examination
- StudyEvent: ODM
Beskrivning
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Beskrivning
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Beskrivning
Physical Examination
Datatyp
integer
Alias
- UMLS CUI [1]
- C0031809
Beskrivning
If ABNORMAL, describe concisely
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C0031809
- UMLS CUI [1,2]
- C0243095
Beskrivning
Physical examination abnormal finding description
Datatyp
text
Alias
- UMLS CUI [1,1]
- C2826636
- UMLS CUI [1,2]
- C0678257
Similar models
Physical Examination
- StudyEvent: ODM
C0243095 (UMLS CUI [1,2])
C0678257 (UMLS CUI [1,2])
Inga kommentarer